GlassScriptPhysician profile
Luke W Swaszek
NPI 1245723303
$3,910.57
in general payments reported to CMS, 2019-2025
9 companies · $576 in 2025
The $576 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $362 · 2024: $2,973 · 2025: $576.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,312 · Food and Beverage: $1,598.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,312.25 |
| Food and Beverage | $1,598.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $1,527.42 | 2023-2024 | Phasix Mesh |
| Medical Device Business Services, INC. | $1,398.86 | 2024 | Echelon Flex |
| Medtronic, INC. | $305.45 | 2023-2024 | Signia |
| Organogenesis INC. | $235.97 | 2025 | Apligraf, Affinity, Puraply Wound Matrix |
| Kerecis Limited | $196.00 | 2024-2025 | Kerecis Surgiclose, Kerecis Graftguide, Kerecis Omega3 Marigen |
| Boston Scientific Corporation | $131.54 | 2025 | Spyglass Discover |
| Enterra Medical, INC. | $76.03 | 2023 | |
| Solventum Corporation | $33.93 | 2025 | Activ.A.C. |
| Intuitive Surgical, INC. | $5.37 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Luke Swaszek listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.